Containing the Impact and Investigating The Long-Lasting Effects of COVID-19
A Virtual Conversation with Dr. Raymond H. Cypess, Chairman and CEO of ATCC
Tuesday, April 5, at 7 PM EST on Zoom
Science Writers in New York is pleased to present Raymond H. Cypess, DVM, PhD, chairman and CEO of ATCC, the world’s premier biological materials management and standards organization. On February 15, ATCC announced that it had been awarded three grants valued at over $5.5 million by the Defense Threat Reduction Agency (DTRA). The work will identify and characterize novel therapeutic approaches to viruses of global health concern.
Dr. Cypess will discuss with SWINY co-chair David Levine (@dlloydlevine) ATCC’s role in detecting and preventing the next pandemic. In the past ATCC partnered with the global scientific community in previous public health emergencies—such as Zika, SARS-CoV, MERS-CoV, and the influenza A H1N1 2009 pandemic. ATCC offers researchers a range of tools and resources to contain the impact and investigate the long-lasting effects of the coronavirus disease, such as cell lines for virus growth, vaccine development, respiratory studies, and immune research.
About Dr. Raymond H. Cypess
Raymond H. Cypess, D.V.M., Ph.D., joined ATCC from the University of Tennessee, Memphis, where he was dean of the College of Graduate Health Sciences, professor of microbiology, immunology and comparative medicine, and vice provost for research and research training. During his leadership there, he created two new academic service departments: Biomedical Engineering and Comparative Medicine.
In addition, he developed center wide core infrastructure units, led a successful strategy that significantly increased the research funding of the university and was awarded the University of Tennessee Memphis College of Medicine Outstanding Teacher Award five years running (1989–1993). Earlier in his career, he was an associate professor of epidemiology and microbiology at the University of Pittsburgh School of Public Health and professor and chairman at the New York State College of Veterinary Medicine.
Dr. Cypess participated on the scientific review boards of the National Institute of Allergy and Infectious Diseases, was part of various National Institutes of Health study sections and served on several editorial boards. He is the author of more than 80 chapters, reviews, and journal articles; a fellow of the Infectious Disease Society; and a member of the American Epidemiology Society.
Dr. Cypess holds a doctorate in veterinary medicine from the University of Illinois and a doctorate in parasitology from the University of North Carolina.
ATCC is a premier global biological materials and information resource and standards organization and the leading developer and supplier of authenticated cell lines and microorganisms. With a history of scientific advancements spanning nearly a century, ATCC offers an unmatched combination of being the world’s largest and most diverse collection of biological research solutions and a mission-driven, trusted partner that supports and encourages scientific collaboration. ATCC products, services and people provide the scientific community with credible biological products, advanced model systems and custom solutions that support complex research in a variety of innovative applications resulting in incredible achievements in basic science, drug discovery, translational medicine, and public health. ATCC is a nonprofit organization with headquarters in Manassas, Virginia, and a research and development innovation center in Gaithersburg, Maryland.
Have a question for Dr. Cypess you would like answered? Submit it here!
Tuesday, April 5
7 to 8 pm EST